apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Leugard 11.25 Depot Injection

  3. Leugard 11.25 Depot Injection Substitute

Leugard 11.25 Depot Injection Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

LEUPRORELIN-11.25MG

Uses:

Treatment of Prostate cancer, Breast cancer, Endometriosis, Premature puberty

Medicinal Benefits:

Leugard 11.25 Depot Injection contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leugard 11.25 Depot Injection is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink.  Also, Leugard 11.25 Depot Injection is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leugard 11.25 Depot Injection delays the onset of puberty in children.

FAQs

Leugard 11.25 Depot Injection contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Leugard 11.25 Depot Injection is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.

Leugard 11.25 Depot Injection may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.

Leugard 11.25 Depot Injection should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Leugard 11.25 Depot Injection and inform your doctor if you have diabetes before taking Leugard 11.25 Depot Injection.

Leugard 11.25 Depot Injection may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Leugard 11.25 Depot Injection reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.

Leugard 11.25 Depot Injection may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Leugard 11.25 Depot Injection.

Leugard 11.25 Depot Injection should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Leugard 11.25 Depot Injection.

No, Leugard 11.25 Depot Injection is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.

Yes, Leugard 11.25 Depot Injection is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.

The common side effects of Leugard 11.25 Depot Injection are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.

Leugard 11.25 Depot Injection belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.